Natco Pharma Ltd. (NATP)

686.50 -17.35 (-2.47%)
Real-time Data INR Disclaimer

NATP Financial Summary

For the nine months ended 31 December 2021, Natco Pharma Ltd. revenues decreased 22% to RS13.48B. Net income decreased 43% to RS2.21B. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Other expenses increase of 13% to RS4.66B (expense), Depreciation and amortisation expense increase of 21% to RS1.05B (expense).
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
NATP
Gross margin TTM 81%
Operating margin TTM 13.3%
Net Profit margin TTM 16.29%
Return on Investment TTM -
Total Revenue
Net Income
Title
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Total Revenue 5,605 3,772 4,103 3,313
Gross Profit 4,675 2,847 3,312 2,768
Operating Income 658 358 760 458
Net Income 804 651 750 530
Clear All
0Selected
Please try another search
NATP
Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets
Total Liabilities
Title
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Total Assets 50,517 47,919
Total Liabilities 8,230 6,703
Total Equity 42,287 41,216
Clear All
0Selected
Please try another search
NATP
Cash Flow/Share TTM 22.38
Revenue/Share TTM 92.03
Operating Cash Flow -
Cash
Net Change in Cash
Title
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Cash From Operating Activities -499 2,988
Cash From Investing Activities 517 -1,033
Cash From Financing Activities 486 -1,857
Net Change in Cash 440 60
Clear All
0Selected
Please try another search

* In Millions of INR (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles